Last reviewed · How we verify
patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients patent landscape — cliff calendar, originator estates, attackable patents
- patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients treatment landscape brief
- patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients treatment updates RSS
Related
- Treatment landscape: patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients patent cliff · patients with type 2 dm who underwent coronary angiography due to coronary artery disease and presence of microvascular complications in same patients CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing